321 related articles for article (PubMed ID: 25158955)
1. Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.
Lee SC; Fujiwara Y; Liu J; Yue J; Shimizu Y; Norman DD; Wang Y; Tsukahara R; Szabo E; Patil R; Banerjee S; Miller DD; Balazs L; Ghosh MC; Waters CM; Oravecz T; Tigyi GJ
Mol Cancer Res; 2015 Jan; 13(1):174-85. PubMed ID: 25158955
[TBL] [Abstract][Full Text] [Related]
2. Uncovering unique roles of LPA receptors in the tumor microenvironment.
Lee SC; Fujiwara Y; Tigyi GJ
Receptors Clin Investig; 2015; 2(1):. PubMed ID: 26005700
[TBL] [Abstract][Full Text] [Related]
3. Different effects of lysophosphatidic acid receptor-2 (LPA
Ishimoto K; Minami A; Minami K; Ueda N; Tsujiuchi T
J Recept Signal Transduct Res; 2021 Feb; 41(1):93-98. PubMed ID: 32672083
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cellular functions through induction of LPA
Takahashi K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
Mol Cell Biochem; 2017 Jul; 431(1-2):29-35. PubMed ID: 28205098
[TBL] [Abstract][Full Text] [Related]
5. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
6. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
[TBL] [Abstract][Full Text] [Related]
7. Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.
Zhao Y; Tong J; He D; Pendyala S; Evgeny B; Chun J; Sperling AI; Natarajan V
Respir Res; 2009 Nov; 10(1):114. PubMed ID: 19930563
[TBL] [Abstract][Full Text] [Related]
8. Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells.
Fukushima K; Otagaki S; Takahashi K; Minami K; Ishimoto K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Aug; 38(4):367-371. PubMed ID: 30396320
[TBL] [Abstract][Full Text] [Related]
9. LPA
Mathew D; Kremer KN; Strauch P; Tigyi G; Pelanda R; Torres RM
Front Immunol; 2019; 10():1159. PubMed ID: 31231367
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
Schleicher SM; Thotala DK; Linkous AG; Hu R; Leahy KM; Yazlovitskaya EM; Hallahan DE
PLoS One; 2011; 6(7):e22182. PubMed ID: 21799791
[TBL] [Abstract][Full Text] [Related]
11. The autotaxin-LPA2 GPCR axis is modulated by γ-irradiation and facilitates DNA damage repair.
Balogh A; Shimizu Y; Lee SC; Norman DD; Gangwar R; Bavaria M; Moon C; Shukla P; Rao R; Ray R; Naren AP; Banerjee S; Miller DD; Balazs L; Pelus L; Tigyi G
Cell Signal; 2015 Sep; 27(9):1751-62. PubMed ID: 26027517
[TBL] [Abstract][Full Text] [Related]
12. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.
Panchatcharam M; Miriyala S; Yang F; Rojas M; End C; Vallant C; Dong A; Lynch K; Chun J; Morris AJ; Smyth SS
Circ Res; 2008 Sep; 103(6):662-70. PubMed ID: 18703779
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
Park SY; Jeong KJ; Panupinthu N; Yu S; Lee J; Han JW; Kim JM; Lee JS; Kang J; Park CG; Mills GB; Lee HY
Oncogene; 2011 Mar; 30(11):1351-9. PubMed ID: 21102517
[TBL] [Abstract][Full Text] [Related]
16. LPA
Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
[TBL] [Abstract][Full Text] [Related]
17. Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents.
Murai N; Hiyama H; Kiso T; Sekizawa T; Watabiki T; Oka H; Aoki T
Neuropharmacology; 2017 Nov; 126():97-107. PubMed ID: 28859883
[TBL] [Abstract][Full Text] [Related]
18. New insights into the autotaxin/LPA axis in cancer development and metastasis.
Leblanc R; Peyruchaud O
Exp Cell Res; 2015 May; 333(2):183-189. PubMed ID: 25460336
[TBL] [Abstract][Full Text] [Related]
19. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
[TBL] [Abstract][Full Text] [Related]
20. Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.
Altman MK; Gopal V; Jia W; Yu S; Hall H; Mills GB; McGinnis AC; Bartlett MG; Jiang G; Madan D; Prestwich GD; Xu Y; Davies MA; Murph MM
Mol Cancer; 2010 Jun; 9():140. PubMed ID: 20529378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]